M. van Domselaar

发表

Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.

J. Gisbert, C. Brensinger, J. Lewis, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease

J. Gisbert, M. Chaparro, S. Riestra, 2018, Journal of Crohn's & colitis.

Complete remission of a primary rectal lymphoma on ulcerative colitis, after withdrawal of azathioprine and infliximab.

M. van Domselaar, A. López San Román, M. Rivero, 2008, Journal of Crohn's & colitis.

Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study.

J. Gisbert, X. Calvet, M. Piqueras, 2019, Journal of Crohn's & colitis.

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study

J. Gisbert, I. Bastón-Rey, D. Busquets, 2022, Inflammatory Bowel Diseases.

Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease

J. Gisbert, M. Chaparro, S. Riestra, 2017, Journal of Crohn's & colitis.

Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience.

J. Gisbert, M. Chaparro, F. Bermejo, 2011, Gastroenterologia y hepatologia.

Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study

J. Gisbert, X. Calvet, M. Chaparro, 2016, Inflammatory bowel diseases.

Predictors of favourable outcome in inflammatory Crohn's disease. A retrospective observational study.

E. Cabré, A. López-Sanromán, J. Gordillo, 2013, Gastroenterologia y hepatologia.

Does active smoking really influence the course of Crohn's disease? A retrospective observational study.

E. Cabré, J. Gordillo, E. Doménech, 2013, Journal of Crohn's & colitis.

Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.

E. Cabré, J. Gordillo, E. Doménech, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Perianal disease in patients with ulcerative colitis: A case-control study.

E. Cabré, J. Gordillo, E. Doménech, 2011, Journal of Crohn's & colitis.

Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease

J. Gisbert, E. Martí-Bonmatí, X. Calvet, 2017, Journal of Crohn's & colitis.

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

J. Gisbert, X. Calvet, M. Piqueras, 2022, Frontiers in Medicine.

Intensification of infliximab therapy in Crohn's disease: efficacy and safety.

J. Mate, J. Gisbert, A. Román, 2012, Journal of Crohn's & colitis.

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.

J. Gisbert, X. Calvet, M. Dominguez-Cajal, 2019, Inflammatory bowel diseases.

Effectiveness and safety of the switch from Remicade to CT-P13 in patients with inflammatory bowel disease.

J. Gisbert, X. Calvet, D. Bernardo, 2019, Journal of Crohn's & colitis.

Diagnostic Yield and Safety of Endoscopic Ultrasound Guided Fine Needle Aspiration of Central Mediastinal Lung Masses

M. Levy, E. Vazquez-Sequeiros, A. Albillos, 2013, Diagnostic and therapeutic endoscopy.

Switching to a second thiopurine in adult and elderly patients with inflammatory bowel disease: a nationwide study from the ENEIDA registry.

J. Gisbert, X. Calvet, S. Riestra, 2020, Journal of Crohn's & colitis.

Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry.

M. J. Cabello, J. Gisbert, D. Busquets, 2022, Digestive and Liver Disease.

[Lymphoproliferative disorders in an inflammatory bowel disease unit].

M. van Domselaar, A. López San Román, M. Bastos Oreiro, 2010, Gastroenterologia y hepatologia.

Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

Blanca Belloc, D. Hervás, L. Bujanda, 2016, Journal of Gastroenterology.

Efectiveness And Safety Of Ustekinumab In Elderly Patients With Crohn's Disease: Real World Evidence From The Eneida Registry.

J. Gisbert, L. Bujanda, M. Chaparro, 2022, Journal of Crohn's & colitis.

Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

J. Gisbert, Blanca Belloc, D. Hervás, 2017, Journal of Gastroenterology.

Idiopathic acute pancreatitis in patients with inflammatory bowel disease: A multicenter cohort study.

S. Riestra, A. Gutiérrez, J. Cameo, 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

J. Gisbert, I. Bastón-Rey, D. Busquets, 2022, Journal of clinical medicine.

Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP

J. Gisbert, M. Chaparro, S. Riestra, 2023, Journal of clinical medicine.

[Efficacy of premedication with intravenous corticosteroids and antihistaminics in preventing infusion reactions to infliximab].

F. Bermejo, A. Algaba, M. van Domselaar, 2008, Gastroenterologia y hepatologia.

P462 Efficacy of ustekinumab for the prevention of postoperative recurrence in crohn’s disease. Data from clinical practice from the eneida registry

D. Busquets, M. Martín-Arranz, M. Iborra, 2020, Journal of Crohn's and Colitis.

Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.

J. Gisbert, C. Brensinger, J. Lewis, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Real‐world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA‐SWITCH study

J. Gisbert, L. Bujanda, M. Chaparro, 2023, Alimentary pharmacology & therapeutics.

Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry.

F. Mesonero, F. Argüelles-Arias, B. Sicilia, 2024, Alimentary pharmacology & therapeutics.

Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project.

A. Lucendo, D. Busquets, F. Mesonero, 2024, Postgraduate medical journal.